Utilizing Available Biomarkers to Tailor and Individualize Therapy in Diabetes

Sponsored by: DiaSorin
Speakers
  • Assistant Professor of Medicine, Section of Endocrinology, Diabetes, and Metabolism, Center for Metabolic Disease and Research, Lewis Katz School of Medicine at Temple University
    Biography
      Dr. Ajay Rao is a board-certified endocrinologist specializing in diabetes and cardiovascular disease and the Lewis Katz School of Medicine at Temple University in Philadelphia, PA. Dr. Rao completed his Internal Medicine residency training at the Lahey Clinical Medical Center in Burlington, MA and followed this with a 2-year clinical endocrinology fellowship at the Tulane University Health Sciences Center in New Orleans, LA where he was involved in landmark clinical trials in diabetes such as ACCORD and TINSAL-T2D. He also went through a critical care fellowship at the University of Pittsburgh Medical Center in Pittsburgh, PA before finishing a 3-year research fellowship at the Brigham and Women's Hospital/Harvard Medical School in Boston, MA. Dr. Rao also received a Masters in Medical Sciences from the Harvard Medical School. His clinical expertise is in diabetes and cardiovascular disease and has research interests in diabetes and residual cardiovascular risk.

    Abstract:

    Almost 1.5 million Americans are diagnosed with diabetes every year.  In 2012 alone, close to 10% of the population has diabetes and about a third of these individuals do not even know they have diabetes.

    More importantly, diabetes remains the 7th leading cause of death in the United States.  In the US, close to $245 billion is spent on individuals with diabetes.  Rendering patients under good glucose control remains the cornerstone of diabetes management.  However, tailoring treatment to the individual is crucial in achieving these goals.  In this talk, Dr. Ajay Rao will go over the laboratory tools available to clinicians to guide their choice of therapeutics for patients with diabetes.

    Learning Objectives:

    • Understand the epidemiology of Type 1 and Type 2 Diabetes
    • Understand the complexities in distinguishing Type 1 from Type 2 Diabetes in the modern-day clinical setting
    • Understand the role of utilizing available biomarkers in order to tailor therapy in diabetes 

    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    Loading Comments...
    Show Resources